Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M FARBER

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Archives of Dermatology|July 1, 1975
Histocompatibility (HL-A) antigens in psoriasisL Krulig, E M Farber, F C Grumet, et al.
Journal of the American Academy of Dermatology|February 1, 1986
Stress, symmetry, and psoriasis: possible role of neuropeptidesE M Farber, B J Nickoloff, B Recht, et al.
JAMA|April 2, 1982
Cost-effectiveness of PUVA therapy: Further considerationsE M Farber, E A Abel, J H Epstein, et al.
The British Journal of Dermatology|March 1, 1978
HLA C and D antigens associated with psoriasisA J McMichael, V Morhenn, R Payne, et al.
Archives of Dermatological Research|January 1, 1987
Topical treatment of psoriasis with the topoisomerase inhibitors novobiocin and nalidixic acid: a pilot studyV A Bohr, E A Abel, E M Farber, et al.
Archives of Dermatology|August 1, 1979
Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasisM S Proctor, D I Wilkinson, E K Orenberg, et al.
The British Journal of Dermatology|July 25, 2000
Nerve growth factor and its receptor system in psoriasisS P Raychaudhuri, W Y Jiang, B R Smoller, et al.
Journal of the American Academy of Dermatology|October 1, 1991
Peptide T improves psoriasis when infused into lesions in nanogram amountsE M Farber, E N Cohen, D J Trozak, et al.
Archives of Dermatology|May 1, 1972
Topical therapy of psoriasis with mechlorethamineH S Zackheim, J E Arnold, E M Farber, et al.
The Journal of Investigative Dermatology|May 1, 1975
Epidermal synthesis of prostaglandins and their effect on levels of cyclic adenosine 3', 5'monophosphateK Aso, D G Deneau, L Krulig, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Archives of Dermatology|July 1, 1975
Histocompatibility (HL-A) antigens in psoriasisL Krulig, E M Farber, F C Grumet, et al.
Journal of the American Academy of Dermatology|February 1, 1986
Stress, symmetry, and psoriasis: possible role of neuropeptidesE M Farber, B J Nickoloff, B Recht, et al.
JAMA|April 2, 1982
Cost-effectiveness of PUVA therapy: Further considerationsE M Farber, E A Abel, J H Epstein, et al.
The British Journal of Dermatology|March 1, 1978
HLA C and D antigens associated with psoriasisA J McMichael, V Morhenn, R Payne, et al.
Archives of Dermatological Research|January 1, 1987
Topical treatment of psoriasis with the topoisomerase inhibitors novobiocin and nalidixic acid: a pilot studyV A Bohr, E A Abel, E M Farber, et al.
Archives of Dermatology|August 1, 1979
Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasisM S Proctor, D I Wilkinson, E K Orenberg, et al.
The British Journal of Dermatology|July 25, 2000
Nerve growth factor and its receptor system in psoriasisS P Raychaudhuri, W Y Jiang, B R Smoller, et al.
Journal of the American Academy of Dermatology|October 1, 1991
Peptide T improves psoriasis when infused into lesions in nanogram amountsE M Farber, E N Cohen, D J Trozak, et al.
Archives of Dermatology|May 1, 1972
Topical therapy of psoriasis with mechlorethamineH S Zackheim, J E Arnold, E M Farber, et al.
The Journal of Investigative Dermatology|May 1, 1975
Epidermal synthesis of prostaglandins and their effect on levels of cyclic adenosine 3', 5'monophosphateK Aso, D G Deneau, L Krulig, et al.
Pageof 15